Partial year: Data through Q3 2025 (Sept 30). Full-year totals not yet available.
YL

Yanke Liang

CT C4 Therapeutics: 2 patents #3 of 22Top 15%
DI Dana-Farber Cancer Institute: 2 patents #15 of 203Top 8%
Hoffmann-La Roche: 1 patents #63 of 289Top 25%
TI The Broad Institute: 1 patents #64 of 310Top 25%
The General Hospital: 1 patents #44 of 343Top 15%
📍 Belmont, MA: #4 of 174 inventorsTop 3%
🗺 Massachusetts: #370 of 11,797 inventorsTop 4%
Overall (2025): #19,004 of 469,880Top 5%
5
Patents 2025

Issued Patents 2025

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
12421220 Bicyclic-substituted glutarimide cereblon binders Christopher G. Nasveschuk, Kiel Lazarski, Alexander Hird, Ning Yin, Andrew C. Good +3 more 2025-09-23
12398145 Bicyclic urea kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi, Thomas Sundberg, Alykhan Shamji, Ramnik Xavier +2 more 2025-08-26
12371442 Isoindolinone and indazole compounds for the degradation of EGFR Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Alexander Hird, Ryan E. Michael +5 more 2025-07-29
12209076 Imidazolyl kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi 2025-01-28
12209091 Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers Martin Duplessis, Annick Goergler, Georg Jaeschke, Buelent Kocer, Bernd Kuhn +6 more 2025-01-28